Market cap
₹27 Cr
Revenue (TTM)
₹72 Cr
P/E Ratio
10.8
P/B Ratio
1.4
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 14.78 | 38.94 | -- |
| EBIT | -- | -- | 32.49 | 76.17 | -- |
| Net Profit | -- | -- | 43.82 | 98.86 | -- |
| EPS | -- | -- | 46.93 | 80.75 | -- |
| Book Value | -- | -- | 16.84 | 13.47 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| 4.87 | -- | 5.44 | 4.71 | 4.47 |
| Net Margin
| 3.09 | -- | 3.88 | 3.10 | 2.28 |
| Return on equity
| 13.48 | -- | 18.22 | 15.05 | 7.15 |
| Return on Capital
| 13.83 | -- | 17.78 | 14.23 | 9.48 |
| Return on Assets
| 4.90 | -- | 6.62 | 5.46 | 2.61 |
| Debt to Equity (x)
| -- | -- | 0.47 | 0.59 | 0.88 |
Profitability
ROCE
17.78
Higher than Peers by 3.55
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
17.78
|
14.23
|
9.48
|
5.00
|
2.83
|
|
Peer Median
|
14.23
|
13.72
|
22.53
|
4.15
|
--
|
ROE
18.22
Higher than Peers by 8.88
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
18.22
|
15.05
|
7.15
|
4.58
|
3.28
|
|
Peer Median
|
9.34
|
9.55
|
16.92
|
2.80
|
--
|
ROA
6.62
Higher than Peers by 1.17
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
6.62
|
5.46
|
2.61
|
1.55
|
0.83
|
|
Peer Median
|
5.46
|
5.81
|
9.16
|
1.50
|
--
|
EBIT Margin
5.44
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
5.44
|
4.71
|
4.47
|
2.67
|
5.56
|
|
Peer Median
|
--
|
12.51
|
14.18
|
3.72
|
--
|
Net Margin
3.88
Higher than Peers by 0.78
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
3.88
|
3.10
|
2.28
|
1.33
|
2.47
|
|
Peer Median
|
3.10
|
3.56
|
4.62
|
4.10
|
--
|
Cash Profit Margin
6.43
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
6.43
|
6.01
|
7.74
|
2.39
|
4.43
|
|
Peer Median
|
--
|
0.00
|
--
|
0.00
|
--
|
Revenue Growth
14.78
--
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
14.78
|
77.91
|
31.34
|
340.97
|
--
|
|
Peer Median
|
--
|
38.08
|
18.84
|
24.28
|
--
|
EBIT Growth
32.49
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
32.49
|
87.59
|
120.00
|
111.50
|
--
|
|
Peer Median
|
--
|
460.14
|
225.64
|
-15.80
|
--
|
Net Profit Growth
43.82
--
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
43.82
|
140.24
|
127.60
|
137.20
|
--
|
|
Peer Median
|
--
|
-3.95
|
200.69
|
13.25
|
--
|
EPS Growth
46.93
--
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
46.93
|
159.24
|
55.04
|
86.45
|
--
|
|
Peer Median
|
--
|
90.91
|
--
|
13.25
|
--
|
Book Value Growth
16.84
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
16.84
|
21.20
|
6.68
|
139.41
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.47
Higher than Peers by 0.43
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
0.47
|
0.59
|
0.88
|
0.66
|
1.64
|
|
Peer Median
|
0.04
|
0.00
|
0.03
|
0.07
|
--
|
Short term debt to equity ratio
0.19
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
0.19
|
0.21
|
0.26
|
0.39
|
0.39
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.40
Lower than Peers by 0.69
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
1.40
|
1.48
|
1.62
|
1.36
|
1.73
|
|
Peer Median
|
2.10
|
2.00
|
2.04
|
2.16
|
--
|
Quick Ratio
0.97
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
0.97
|
0.93
|
1.03
|
0.93
|
1.22
|
|
Peer Median
|
--
|
3.80
|
3.16
|
2.23
|
--
|
Interest Coverage
14.43
Lower than Peers by 1.80
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
14.43
|
4.73
|
2.40
|
1.56
|
1.92
|
|
Peer Median
|
16.23
|
8.29
|
13.76
|
3.36
|
--
|
Operating Efficiency
Debtors to sales
29.52
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
29.52
|
21.49
|
35.51
|
34.05
|
117.92
|
|
Peer Median
|
--
|
27.50
|
40.47
|
26.09
|
--
|
Asset Turnover
1.70
--
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
1.70
|
1.75
|
1.13
|
1.17
|
0.34
|
|
Peer Median
|
--
|
1.26
|
1.17
|
0.64
|
--
|
Receivable days
88.04
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
88.04
|
75.65
|
112.12
|
110.95
|
430.39
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
50.06
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
50.06
|
51.52
|
74.90
|
69.97
|
260.50
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
86.28
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
86.28
|
71.29
|
130.73
|
114.01
|
456.30
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
51.82
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
51.82
|
55.88
|
56.29
|
66.91
|
234.60
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
17.09
Lower than Peers by 13.75
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
17.09
|
15.62
|
38.86
|
32.21
|
--
|
|
Peer Median
|
30.84
|
47.94
|
40.22
|
94.75
|
--
|
Price / Book Value
2.40
Lower than Peers by 3.98
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
2.40
|
3.49
|
1.96
|
1.12
|
--
|
|
Peer Median
|
6.38
|
4.56
|
4.89
|
3.81
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
0.08
|
--
|
--
|
--
|
EV/EBITDA
7.68
Lower than Peers by 22.35
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
7.68
|
11.51
|
8.57
|
18.31
|
21.40
|
|
Peer Median
|
30.04
|
35.83
|
23.03
|
-2.86
|
--
|
Market Cap
40
Lower than Peers by 229
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Walpar Nutritions
|
40
|
49
|
23
|
12
|
--
|
|
Peer Median
|
268
|
133
|
112
|
40
|
--
|